Browse the entire story.

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health Information, an editorially independent news service, is a scheduled system of the Kaiser Family Foundation, a nonpartisan healthcare policy research company unaffiliated with Kaiser Permanente., a manufacturer and developer of medical devices for the administration and treatment of prostatic obstruction, announced today that it offers received PMA authorization from the united states Food and Medication Administration for style changes with their flagship product, The Spanner Prostatic Stent.Principal analyses were performed on an intention-to-treat basis. Furthermore, a per-protocol analysis, limited to the topics who received treatment in full accordance with the scholarly research protocol, was conducted. All statistical lab tests were two-sided; P ideals of less than 0.05 were thought to indicate statistical significance. All analyses were performed by using SAS software, version 9.1. Results Characteristics and Enrollment of the Patients Between 1998 and September 2003 November, a total of 201 patients were screened for eligibility .